SEC Company Response from GENESCO (GCO) — Jul 11, 2008
GENESCO INC
Date: July 11, 2008 · CIK: 0000018498 · Accession: 0000950144-08-005455
AI Filing Summary & Sentiment
File numbers found in text: 001-03083
Referenced dates: July 7, 2008
Show Raw Text
CORRESP
1
filename1.htm
Correspondence letter to the SEC
July 11, 2008
VIA EDGAR
Pamela Howell
Special Counsel
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
Genesco Inc.
Form 10-K for fiscal year ended February 2, 2008
Filed April 2, 2008
File No. 001-03083
Dear Ms. Howell:
On behalf of Genesco Inc. (the “Company”), set forth below is the Company’s response to your
comment letter dated July 7, 2008, regarding certain executive compensation disclosures in the
Company’s Definitive Proxy Statement on Schedule 14A that was filed with the Securities and
Exchange Commission on May 8, 2008. To facilitate your review, we have included in this letter the
captions and comment from your letter and have provided our response immediately following the
comment.
Schedule 14A, Filed May 8, 2008
Compensation, Discussion and Analysis, page 16:
1.
We note the disclosure on page 22 regarding the individual strategic objectives that comprise
25% of the named executive officers’ annual incentive award. In future filings, clearly
disclose those strategic objectives for each named executive officer. In addition, to the
extent that these strategic objectives are targets, please disclose the specific quantitative
performance targets used to determine incentive amounts in future filings, or provide a
supplemental analysis as to why it is appropriate to omit these targets pursuant to
Instruction 4 to Item 402(b) of Regulation S-K. To the extent that it is appropriate to omit
specific targets, please provide the disclosure pursuant to Instruction 4 to Item 402(b). In
discussing how likely it will be for the company to achieve the target levels or other
factors, provide as much detail as necessary without providing information that poses
reasonable risk of competitive harm.
Pamela Howell
July 11, 2008
Page 2
Response:
The Company acknowledges the Staff’s comment and confirms that, in future filings, the Company will
revise and/or expand its disclosures regarding individual strategic objectives that comprise a
portion of the named executive officers’ annual incentive award. To the extent such objectives
consist of specific quantitative performance targets, the Company will either disclose such targets
or provide the disclosure required by Instruction 4 to Item 402(b) of Regulation S-K.
In connection with responding to your comment, we acknowledge that:
•
The Company is responsible for the adequacy and accuracy of the disclosure in the
filing;
•
Staff comments or changes to disclosure in response to comments do not foreclose the
Commission from taking any action with respect to the filing; and
•
The Company may not assert Staff comments as a defense in any proceeding initiated
by the Commission or any person under the federal securities laws of the United States.
If you have any questions concerning the Company’s response to your comment letter, please do not
hesitate to contact me at (615) 367-8444.
Sincerely,
/s/ Roger G. Sisson
Roger G. Sisson
Senior Vice President, Secretary
and General Counsel